This Article  • References  • Full text PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Citing articles on Web of Science (68)  • Contact me when this article is cited  Related Content  • Similar articles in JAMA  Social Bookmarking   What's this?

Edwin G. Krebs, MD

JAMA. 1989;262(13):1815-1818.

Abstract
The first example of an enzyme that undergoes phosphorylation and dephosphorylation was phosphorylase, which catalyzes the initial step in the breakdown of tissue glycogen, a process that occurs when cells are stimulated by certain hormones. The phosphorylation reaction that activates phosphorylase is catalyzed by an enzyme designated "phosphorylase kinase," whereas the dephosphorylation reaction is catalyzed by an enzyme called "phosphorylase phosphatase." Phosphorylase kinase, like phosphorylase itself, is regulated by phosphorylation-dephosphorylation. In this instance the enzyme is phosphorylated and activated by a protein kinase that is the intracellular target of adenosine 3',5'-cyclic phosphate, the second messenger of hormone action that was discovered by the late Earl Sutherland. Knowledge of these steps led to the establishment of the glycogenolytic cascade in which adenosine 3',5'-cyclic phosphate, formed as a result of hormone action, first activates the adenosine 3',5'-cyclic phosphate—dependent protein kinase, which in turn activates phosphorylase kinase, which then converts inactive phosphorylase to its active form. This is followed by the breakdown of glycogen.

(JAMA. 1989;262:1815-1818)

Author Affiliations
From the Howard Hughes Medical Institute and the Departments of Pharmacology and Biochemistry, University of Washington, Seattle.

Footnotes
Based on a lecture given at the presentation of the Albert Lasker Medical Research Award, New York, NY, September 27, 1989.

Reprint requests to the Howard Hughes Medical Institute, SL-15, University of Washington School of Medicine, Seattle, WA 98195 (Dr Krebs).

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Androgens Transduce the G{alpha}s-Mediated Activation of Protein Kinase A in Prostate Cells
Bagchi et al.
Cancer Res. 2008;68:3225-3231.
ABSTRACT | FULL TEXT  

Proteasome Function Is Regulated by Cyclic AMP-dependent Protein Kinase through Phosphorylation of Rpt6
Zhang et al.
J. Biol. Chem. 2007;282:22460-22471.
ABSTRACT | FULL TEXT  

Structural Analysis of Protein Kinase A Mutants with Rho-kinase Inhibitor Specificity
Bonn et al.
J. Biol. Chem. 2006;281:24818-24830.
ABSTRACT | FULL TEXT  

Microsomal prostaglandin E synthase-1 regulates human glioma cell growth via prostaglandin E2-dependent activation of type II protein kinase A.
Payner et al.
Molecular Cancer Therapeutics 2006;5:1817-1826.
ABSTRACT | FULL TEXT  

Interleukin-1{beta}, Transforming Growth Factor-{beta}1, and Bradykinin Attenuate Cyclic AMP Production by Human Pulmonary Artery Smooth Muscle Cells in Response to Prostacyclin Analogues and Prostaglandin E2 by Cyclooxygenase-2 Induction and Downregulation of Adenylyl Cyclase Isoforms 1, 2, and 4
El-Haroun et al.
Circ. Res. 2004;94:353-361.
ABSTRACT | FULL TEXT  

Altered Temporal Profile of Heat Shock Factor 1 Phosphorylation and Heat Shock Protein 70 Expression Induced by Heat Shock in Nucleus Tractus Solitarii of Spontaneously Hypertensive Rats
Chan et al.
Circulation 2003;107:339-345.
ABSTRACT | FULL TEXT  

Role of cAMP-dependent protein kinase A activity in endothelial cell cytoskeleton rearrangement
Liu et al.
Am. J. Physiol. Lung Cell. Mol. Physiol. 2001;280:L1309-L1317.
ABSTRACT | FULL TEXT  

Decreased Vasodilator Response to Isoproterenol During Nitric Oxide Inhibition in Humans
Cardillo et al.
Hypertension 1997;30:918-921.
ABSTRACT | FULL TEXT